Your news subscription: Chemicals is now Life Science and Performance Materials
- You will automatically receive both news categories
- You may change your subscription any time
You have subscribed to receive our “Chemicals” news releases. In line with our transformation into a leading science and technology company, you will now receive news from both our Life Science and Performance Materials business sectors, unless you change your subscription on www.emdgroup.com/subscribe to specify one of the two and then reactivate your new subscription in the e-mail this generates. To decide which news releases you would like to receive, please refer to latest news from >>MilliporeSigma and from and from >>EMD Performance Materials on our website.
Across Healthcare, Life Science and Performance Materials, we advance technologies for life by bringing specialist and high-quality products to patients, consumers and business associates around the world.
Discover more at www.emdgroup.com.
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck KGaA, Darmstadt, Germany, generated sales of € 12.85 billion in 66 countries.
Founded in 1668, Merck KGaA, Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck KGaA, Darmstadt, Germany, holds the global rights to the „Merck” name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
Merck KGaA today shared updates on the company’s healthcare research and development strategy, aimed at doubling R&D productivity.